Screener
NovoCure NVCR Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from NovoCure’s reported figures.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 | Year ended December 31, 2025 |
|---|---|---|---|---|---|
| Net revenues | $183,584 | $158,805 | $357,639 | $313,799 | $655,353 |
| Cost of revenues | 41,106 | 41,472 | 80,035 | 79,993 | 166,879 |
| Gross profit | 142,478 | 117,333 | 277,604 | 233,806 | 488,474 |
| Operating costs and expenses: | |||||
| Research, development and clinical studies | 51,448 | 55,833 | 109,784 | 109,610 | 224,544 |
| Sales and marketing | 61,684 | 57,066 | 120,041 | 112,858 | 240,064 |
| General and administrative | 39,908 | 43,955 | 125,761 | 88,724 | 177,666 |
| Total operating costs and expenses | 153,040 | 156,854 | 355,586 | 311,192 | 642,274 |
Item 1. Financial Statements
FAQ
- What is NovoCure's gross profit?
- NovoCure (NVCR) reported gross profit of $142.48M in Q2 2026.
- How has NovoCure's gross profit changed year-over-year?
- NovoCure's gross profit increased by 21.4% year-over-year, from $117.33M to $142.48M.
- What is the long-term trend for NovoCure's gross profit?
- Over 4 years (2021 to 2025), NovoCure's gross profit has grown at a 3.8% compound annual growth rate (CAGR), from $420.15M to $488.47M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about NovoCure's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude